Health
Metformin treatment linked to slowed cognitive decline – WebWire
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels. A new research study, conducted over six year…
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels.
A new research study, conducted over six years in the Sydney Memory and Ageing Study in 1037 Australians (aged 70 to 90 years old at baseline), has revealed an additional effect: individuals with type 2 diabetes who used metformin experienced slower cognitive decline with lower dementi…
-
General23 hours agoVictorian school teacher charged with soliciting child abuse material
-
General14 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News20 hours agoFuel tanker driver killed in horror head-on crash near Blackbutt identified as beloved father-of-two
-
Noosa News18 hours agoPalestine protesters forced into last-minute reroute